<DOC>
	<DOC>NCT01555086</DOC>
	<brief_summary>This study examines Limited versus extended pelvic lymphadenectomy.</brief_summary>
	<brief_title>Prospective Study to Compare a Limited Versus Extended Pelvic Lymphadenectomy During Prostatectomy</brief_title>
	<detailed_description>This study is meant to show if the extension of lymphadenectomy during prostatectomy has an influence of outcome of patients. Patients with indication to prostatectomy due to prostate cancer will be included. Both extensions of lymphadenectomy are used in hospitals as a free choice. This study shell show if one method is more effective than the other.</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>stamp bioptic secured prostate cancer with intermediate or high risk profile (defined as GleasonScore 710 or PSA &gt; 10 ng/ml) locallyoperable tumor according to DRU/TRUS negative bone scan negative CT abdomen / pelvis general condition according to Karnofsky &gt;/= 80% written consent of the patient adequate hematological, renal and coagulation physiological functions Patient compliance and geographic proximity to allow adequate followup Manifest secondary malignancy Secured metastasis by histologically or by imaging Myocardial infarction or stroke within the last 6 months Existing major cardiovascular (grade III IV according to NYHA), pulmonary (pO2 &lt;60 mmHg), renal, hepatic or hematopoietic (eg severe bone marrow aplasia) diseases Severe active or chronic infections (eg pos. HIVAb test, HBsAg detection in serum and / or chronic hepatitis) severe psychiatric disease prior chemotherapy (allowed is a preoperative antiandrogen therapy â‰¤ 3 months) previous pelvic radiotherapy Patients in a closed institution according to an authority or court decision People who are in a dependent relationship or working relationship with the sponsor or investigator simultaneous participation in another clinical trial</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Lymphadenectomy</keyword>
	<keyword>Prostate cancer</keyword>
</DOC>